 |
 |
|
|
|
| Mosapride |
 |
| C21H25ClFN3O3 |
 |
| 112885-41-3 |
 |
| clinical for functional dyspepsia with heartburn, belching, nausea, vomiting, early satiety, bloating, abdominal pain and other gastrointestinal symptoms. Can also be used for gastroesophageal reflux disease, stomach dysfunction in patients with diabetic gastroparesis and gastric resection. |
 |
Mosapride
Benzamide,4-amino-5-chloro-2-ethoxy-N-[[4 - [(4-fluorophenyl) methyl]-2-morpholinyl] methyl] -
English alias: Mosapid
Mosapride,
Mosid-MT
Moza
CAS No. :112885-41-3
Molecular Weight: 421.90
MF: C21H25ClFN3O3
Uses: clinical for functional dyspepsia with heartburn, belching, nausea, vomiting, early satiety, bloating, abdominal pain and other gastrointestinal symptoms. Can also be used for gastroesophageal reflux disease, stomach dysfunction in patients with diabetic gastroparesis and gastric resection. |
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
